Medtech Convergence Fund, L.P.
1 additional placement agent
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- +151%reported GAV
Reported gross assets rose from $31.9M to $80.2M between the Form ADV filings of 28 Mar 2024 and 31 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Amounts, each with its basis
- Vintage
- 2019basis: adv first reported
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $94.0Mwhat may be sold, not what was raised; file 021-334664, sworn by the adviser or filed under this vehicle
- Form D sold
- $0as of the filing of Mar 12, 2019
- First sale
- unknown
- Reported GAV
- $80.2Mon the Form ADV filed Mar 31, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 2
- Reported on ADV
- Mar 29, 2019 to Mar 31, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Lifecycle
Mature
Lifecycle
The fund's own reporting through time
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 29, 2019 | Venture Capital Fund | $0 | 0 | 0% | no | ||
| May 29, 2019 | Venture Capital Fund | $0 | 0 | 0% | no | ||
| Mar 30, 2020 | Venture Capital Fund | $13.8M | 1 | 1% | yes | ||
| Mar 31, 2021 | Venture Capital Fund | $84.6M | 2 | 1% | yes | ||
| Apr 29, 2021 | Venture Capital Fund | $84.6M | 2 | 1% | yes | ||
| Mar 31, 2022 | Venture Capital Fund | $89.1M | 2 | 1% | yes | ||
| Mar 30, 2023 | Venture Capital Fund | $90.1M | 2 | 1% | yes | ||
| Mar 28, 2024 | Venture Capital Fund | $31.9M | 2 | 1% | yes | ||
| Mar 31, 2026 | Venture Capital Fund | $80.2M | 2 | 1% |
Principals and agents
- Aaron Sandoski Executive Officer
- Paul Laviolette Executive Officer
- Medtech Convergence GP LLC Executive Officer
Service providers
- AuditorRSM · BOSTON, Massachusetts, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- CustodianBank of America · CHARLOTTE, North Carolina, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- CustodianFirst Citizens Bank · SANTA CLARA, California, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.Investments attributed to this vehicle
Timeline
Evidence
Every observation on this vehicle
- Entity type: Limited Partnership Fact Form D
- Entity type: Limited Partnership Mar 12, 2019 Fact Form D
- Form D fund type: Venture Capital Fund Fact Form D
- Form D fund type: Venture Capital Fund Mar 12, 2019 Fact Form D
- Form D industry group: Pooled Investment Fund Fact Form D
- Form D industry group: Pooled Investment Fund Mar 12, 2019 Fact Form D
- Amendment: false Fact Form D
- Amendment: false Mar 12, 2019 Fact Form D
- Revenue range (Form D): Not Applicable Fact Form D
- Revenue range (Form D): Not Applicable Mar 12, 2019 Fact Form D
- Incorporated: withinFiveYears Fact Form D
- Incorporated: withinFiveYears Mar 12, 2019 Fact Form D
- Jurisdiction: Delaware Fact Form D
- Jurisdiction: Delaware Mar 12, 2019 Fact Form D
- Amount sold (Form D): $0 Fact Form D
- Amount sold (Form D): $0 Mar 12, 2019 Fact Form D
- Offering amount (Form D): $94.0M Fact Form D
- Offering amount (Form D): $94.0M Mar 12, 2019 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Mar 12, 2019 Fact Form D
- Investors (Form D): 0 Fact Form D
- Investors (Form D): 0 Mar 12, 2019 Fact Form D
- Minimum investment (Form D): 0 Fact Form D
- Minimum investment (Form D): 0 Mar 12, 2019 Fact Form D
- Securities offered: pooled Fact Form D
- Securities offered: pooled Mar 12, 2019 Fact Form D
- Office address: Fact Form D
- Office address: Mar 12, 2019 Fact Form D
- Year of incorporation: 2018 Fact Form D
- Year of incorporation: 2018 Mar 12, 2019 Fact Form D
Relationships across DFX
on 1 other DFX graph
Medtech Convergence Fund, L.P. is the same institution as 1 record in RIA and Wealth.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
- Fund first reported on ADV2019-03-29source on record
- Form D filed2019-03-12source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.